VLRX News and Press, Valeritas Holdings

BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...

Gainers:  Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...

Thinly traded nano cap Valeritas Holdings ( VLRX -51.2% ) slumps on almost a 5x surge in volume, albeit on turnover of only 674K shares, in response to its revenue guidance cut due to a manufacturing issue that caused a temporary disruption in product supply. More news on: Valeritas Ho...

Stealth BioTherapeutics (NASDAQ: MITO )  -56%  after elamipretide flunks late-stage PMM study. More news on: Stealth BioTherapeutics Corp, Valeritas Holdings, Inc., Abeona Therapeutics Inc., Stocks on the move, Read more ...

BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced revised revenue guida...

BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...

Thinly traded nano cap Valeritas Holdings (NASDAQ: VLRX ) is up  9%  premarket on modest volume in reaction to new data on its V-Go Wearable Insulin Delivery device. The results were presented at the Annual Diabetes Technology Meeting in Maryland. More news on: Valeritas Holdin...

Plus Therapeutics (NASDAQ: PSTV ) +30%  after Q3 results . More news on: Plus Therapeutics, Inc., Farfetch Limited, RadNet, Inc., Stocks on the move, Read more ...

BRIDGEWATER, N.J., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced additional data from the VERDICT study presented at the 19 th Annual Diabetes Technolog...

Valeritas Holdings, Inc. (VLRX) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations John Timberlake – President and Chief Executive Officer Erick Lucera – Chief Financial Officer Conference...